Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Gene Expression Signature Correlates with Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Everolimus Alone or with a Vascular Disrupting Agent.
Mol Cancer Ther. 2021 Aug;20(8):1454-1461. doi: 10.1158/1535-7163.MCT-20-1091. Epub 2021 Jun 9.
Mol Cancer Ther. 2021.
PMID: 34108261
Clinical Trial.
Loss of HAT1 expression confers BRAFV600E inhibitor resistance to melanoma cells by activating MAPK signaling via IGF1R.
Bugide S, Parajuli KR, Chava S, Pattanayak R, Manna DLD, Shrestha D, Yang ES, Cai G, Johnson DB, Gupta R.
Bugide S, et al. Among authors: manna dld.
Oncogenesis. 2020 May 5;9(5):44. doi: 10.1038/s41389-020-0228-x.
Oncogenesis. 2020.
PMID: 32371878
Free PMC article.
Item in Clipboard
Cite
Cite